Unlocking BioCompute Objects: Advancing Interoperability and Regulatory Excellence.
Date: September 10, 2025
Time: 12 pm PST • 3 pm EST
Velsera is leading the way in making complex Next Generation Sequencing (NGS) workflows more transparent, interoperable, and ready for regulatory review. BioCompute Objects (BCOs) is a standard for documentation to report computational workflows and ease organizational burden for sponsors and FDA reviewers. As an active contributor to the BCO community, Velsera has helped define the BCO standard in collaboration with George Washington University - empowering organizations to clearly communicate computational workflows to regulatory agencies.
The award-winning BCO application automatically generates BCOs from sophisticated workflows, including our Neoantigen Discovery Workflow. This workshop will highlight best practices for regulatory submissions of computational workflows and demonstrate how BCO documentation can accelerate and streamline FDA reviews.
In this session, our experts will:
- Introduce BioCompute Objects (BCOs)
- Explain the implementation on the Cancer Genomics Cloud
- Demonstrate it live by generating a BCO from a CGC workflow and uploading the document to the biocompute servers!
Meet the speakers:

Phillip Webster, Ph.D.
Community Engagement Manager, Velsera
Phil Webster is a member of the Community Engagement team at Velsera, where he brings deep experience in genomics and regulatory science. He earned his Ph.D. in Cell and Structural Biology from the University of Texas Health Science Center San Antonio, with research focused on aging muscle and mitochondrial dysfunction. His career includes work in HIV, neurogenesis, and vascular biology, as well as postdoctoral research on diabetes at the University of Michigan. Since joining Velsera in 2020 as a Genomic Scientist, Phil has helped bridge scientific research with regulatory and community needs.

Jonathon Keeney, Ph.D.
Research Assistant Professor, George Washington University
Jonathon Keeney is a Research Assistant Professor at The George Washington University, where he leads or supports several bioinformatics projects in metagenomics, comparative neuroscience, and viral evolution, among others. He was a key figure in the standardization of BioCompute, and is a Co-Investigator on an FDA-funded project to build tools and training for working with the standard.